Clinical Trials Logo

Clinical Trial Summary

Infiltrations from cannulation difficulties result in significant morbidity including loss of vascular access (VA) loss in hemodialysis (HD). Cannulation is reliant on personnel skill and VA characteristics. Surface marking of VA lacks real-time information and traditional ultrasound (US) devices are large, expensive and require skilled operator expertise. Sonic Window© (Analogic Ultrasound, Peabody, MA) is a coronal mode ultrasound device (CMUD) approved for VA cannulation. Study is a single center randomized, prospective pilot study comparing handheld US-guided cannulation of new arteriovenous fistula (AVF) to standard cannulation practices.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02814721
Study type Interventional
Source Henry Ford Health System
Contact
Status Completed
Phase N/A
Start date March 2015
Completion date December 2015